Literature DB >> 28830639

T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.

Eduardo Vadillo1, Elisa Dorantes-Acosta2, Rosana Pelayo3, Michael Schnoor4.   

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood and adult ALL cases, respectively. During T-ALL, patients are at risk of organ infiltration by leukemic T-cells. Infiltration is a major consequence of disease relapse and correlates with poor prognosis. Transendothelial migration of leukemic cells is required to exit the blood stream into target organs. While mechanisms of normal T-cell transmigration are well known, the mechanisms of leukemic T-cell extravasation remain elusive; but involvement of chemokines, integrins and Notch signaling play critical roles. Here, we summarize current knowledge about molecular mechanisms of leukemic T-cell infiltration with special emphasis on the newly identified subtype early T-cell-progenitor (ETP)-ALL. Furthermore, we compare the extravasation potential of T-ALL cells with that of other hematologic malignancies such as B-ALL and acute myeloid leukemia (AML).
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CXCL12; CXCR4; Central nervous system; Diapedesis; Endothelial transmigration; LFA-1; Selectin; T-cells; VLA-4

Mesh:

Substances:

Year:  2017        PMID: 28830639     DOI: 10.1016/j.blre.2017.08.006

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  44 in total

1.  SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia.

Authors:  Qian Kong; Yunyao Li; Qixiang Liang; Jianwei Xie; Xinyu Li; Jianpei Fang
Journal:  Cancer Biol Ther       Date:  2020-01-13       Impact factor: 4.742

2.  HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.

Authors:  Lichun Sun; Quanyong He; Cheguo Tsai; Jun Lei; Jing Chen; Lily Vienna Makcey; David H Coy
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

Review 3.  Metabolic underpinnings of leukemia pathology and treatment.

Authors:  Travis Nemkov; Angelo D'Alessandro; Julie A Reisz
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-07

Review 4.  GSK-3: a multifaceted player in acute leukemias.

Authors:  Alberto M Martelli; Camilla Evangelisti; Francesca Paganelli; Francesca Chiarini; James A McCubrey
Journal:  Leukemia       Date:  2021-04-02       Impact factor: 11.528

5.  Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.

Authors:  Natalia Baran; Alessia Lodi; Yogesh Dhungana; Shelley Herbrich; Meghan Collins; Shannon Sweeney; Renu Pandey; Anna Skwarska; Shraddha Patel; Mathieu Tremblay; Vinitha Mary Kuruvilla; Antonio Cavazos; Mecit Kaplan; Marc O Warmoes; Diogo Troggian Veiga; Ken Furudate; Shanti Rojas-Sutterin; Andre Haman; Yves Gareau; Anne Marinier; Helen Ma; Karine Harutyunyan; May Daher; Luciana Melo Garcia; Gheath Al-Atrash; Sujan Piya; Vivian Ruvolo; Wentao Yang; Sriram Saravanan Shanmugavelandy; Ningping Feng; Jason Gay; Di Du; Jun J Yang; Fieke W Hoff; Marcin Kaminski; Katarzyna Tomczak; R Eric Davis; Daniel Herranz; Adolfo Ferrando; Elias J Jabbour; M Emilia Di Francesco; David T Teachey; Terzah M Horton; Steven Kornblau; Katayoun Rezvani; Guy Sauvageau; Mihai Gagea; Michael Andreeff; Koichi Takahashi; Joseph R Marszalek; Philip L Lorenzi; Jiyang Yu; Stefano Tiziani; Trang Hoang; Marina Konopleva
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

6.  Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis.

Authors:  Junjie Yin; Qingsong Yin; Bo Liang; Ruihua Mi; Hao Ai; Lin Chen; Xudong Wei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-14       Impact factor: 3.000

7.  Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Authors:  Kimberly P Dunsmore; Stuart S Winter; Meenakshi Devidas; Brent L Wood; Natia Esiashvili; Zhiguo Chen; Nancy Eisenberg; Nikki Briegel; Robert J Hayashi; Julie M Gastier-Foster; Andrew J Carroll; Nyla A Heerema; Barbara L Asselin; Karen R Rabin; Patrick A Zweidler-Mckay; Elizabeth A Raetz; Mignon L Loh; Kirk R Schultz; Naomi J Winick; William L Carroll; Stephen P Hunger
Journal:  J Clin Oncol       Date:  2020-08-19       Impact factor: 44.544

8.  CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration.

Authors:  Kirsti L Walker; Sean P Rinella; Nicholas J Hess; David P Turicek; Sabrina A Kabakov; Fen Zhu; Myriam N Bouchlaka; Sydney L Olson; Monica M Cho; Aicha E Quamine; Arika S Feils; Tara B Gavcovich; Lixin Rui; Christian M Capitini
Journal:  Leuk Lymphoma       Date:  2021-04-11

Review 9.  The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Authors:  Marta Weronika Lato; Anna Przysucha; Sylwia Grosman; Joanna Zawitkowska; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

10.  Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report.

Authors:  Martyna Stefaniak; Gabriela Ręka; Joanna Zawitkowska; Monika Lejman
Journal:  BMC Med Genomics       Date:  2021-07-03       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.